Showing 1 - 1 of 1 trials – Showing only trials currently accepting patients
-
Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors
Stanford is currently accepting patients for this trial.